Invention Grant
- Patent Title: Anti-CD40 targeted fusion proteins
- Patent Title (中): 抗CD40靶向融合蛋白
-
Application No.: US12717789Application Date: 2010-03-04
-
Publication No.: US08961991B2Publication Date: 2015-02-24
- Inventor: Gerard Zurawski , Jacques F. Banchereau , Anne-Laure Flamar , Yves Levy , Monica Montes
- Applicant: Gerard Zurawski , Jacques F. Banchereau , Anne-Laure Flamar , Yves Levy , Monica Montes
- Applicant Address: US TX Dallas
- Assignee: Baylor Research Institute
- Current Assignee: Baylor Research Institute
- Current Assignee Address: US TX Dallas
- Agency: Fulbright & Jaworski LLP
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/12 ; A61K39/21 ; A61K39/295 ; C07K19/00 ; C07K2/00 ; A61K39/385 ; C07K14/005 ; C07K16/28 ; G01N33/68
Abstract:
The present invention includes compositions and methods for the expression, secretion and use of novel compositions for use as, e.g., vaccines and antigen delivery vectors, to delivery antigens to antigen presenting cells. In one embodiment, the vector is an anti-CD40 antibody, or fragments thereof, and one or more antigenic peptides linked to the anti-CD40 antibody or fragments thereof, including humanized antibodies.
Public/Granted literature
- US20100297114A1 ANTIGEN PRESENTING CELL TARGETED VACCINES Public/Granted day:2010-11-25
Information query
